United States 116th Congress Status: Died 1 R cosponsors

HR 6925 — Medical Innovation Acceleration Act of 2020

Last action — Referred to the House Committee on Energy and Commerce.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Exempts non-invasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines non-invasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.

Bill Text

We don't have the full text on file for this bill yet.

Read HR 6925 on the official United States source →

Action History

  1. Referred to the House Committee on Energy and Commerce.

  2. Introduced in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Health Administrative remedies Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA)
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 6925 do?
Exempts non-invasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines non-invasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Who sponsors HR 6925?
HR 6925 is sponsored by Andy Biggs (R).
What is the current status of HR 6925?
This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 6925?
Track HR 6925 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 6925

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 6925

Last checked for changes about 14 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →